- Home
- EBS vs CGC Comparison
EBS vs CGC Comparison
Compare EBS & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- CGC
- Stock Information
- Founded
- EBS 1998
- CGC N/A
- Country
- EBS United States
- CGC Canada
- Employees
- EBS N/A
- CGC N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- EBS Health Care
- CGC Health Care
- Exchange
- EBS Nasdaq
- CGC Nasdaq
- Market Cap
- EBS 423.6M
- CGC 431.7M
- IPO Year
- EBS 2006
- CGC N/A
- Fundamental
- Price
- EBS $9.14
- CGC $1.37
- Analyst Decision
- EBS Strong Buy
- CGC Hold
- Analyst Count
- EBS 2
- CGC 1
- Target Price
- EBS $13.50
- CGC N/A
- AVG Volume (30 Days)
- EBS 959.0K
- CGC 23.8M
- Earning Date
- EBS 11-05-2025
- CGC 11-07-2025
- Dividend Yield
- EBS N/A
- CGC N/A
- EPS Growth
- EBS N/A
- CGC N/A
- EPS
- EBS 2.53
- CGC N/A
- Revenue
- EBS $851,600,000.00
- CGC $201,572,742.00
- Revenue This Year
- EBS N/A
- CGC $13.24
- Revenue Next Year
- EBS $19.24
- CGC $3.68
- P/E Ratio
- EBS $3.62
- CGC N/A
- Revenue Growth
- EBS N/A
- CGC N/A
- 52 Week Low
- EBS $4.02
- CGC $0.77
- 52 Week High
- EBS $12.73
- CGC $5.80
- Technical
- Relative Strength Index (RSI)
- EBS 65.40
- CGC 48.83
- Support Level
- EBS $8.58
- CGC $1.32
- Resistance Level
- EBS $9.34
- CGC $1.46
- Average True Range (ATR)
- EBS 0.38
- CGC 0.11
- MACD
- EBS 0.10
- CGC -0.00
- Stochastic Oscillator
- EBS 85.94
- CGC 23.53
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.